At1g06470 is an Arabidopsis gene encoding an integral membrane protein with eight putative transmembrane domains (TMDs) . The protein’s structure suggests potential roles in ion transport, receptor signaling, or membrane trafficking, though experimental validation is limited. Unlike well-characterized transporters (e.g., mitochondrial adenylate translocators or chloroplast envelope proteins), At1g06470 lacks definitive functional annotations .
The At1g06470 antibody is primarily utilized for:
Subcellular localization studies: Confirming membrane association via immunofluorescence or immunogold labeling .
Protein-protein interaction assays: Identifying binding partners in pulldown or co-immunoprecipitation experiments.
Expression profiling: Tracking tissue-specific or stress-induced expression patterns.
Proteomic Identification: At1g06470 was detected in tonoplast-enriched fractions, suggesting a role in vacuolar transport .
Developmental Regulation: Preliminary data indicate higher expression in root tissues, though quantitative validation is pending .
Despite its utility, the At1g06470 antibody faces limitations:
Epitope Specificity: No published validation (e.g., knockout controls) confirms antibody specificity.
Functional Data: No direct links to biochemical pathways or knockout phenotypes exist.
Structural Insights: The absence of crystallography or cryo-EM data hinders mechanistic understanding.
| Gap Area | Priority Level | Potential Approaches |
|---|---|---|
| Functional validation | High | CRISPR-Cas9 knockout lines, transport assays |
| Antibody validation | Medium | Western blotting with mutant tissue |
| Interaction mapping | High | Yeast two-hybrid screens, affinity purification |
At1g06470 contrasts with better-studied membrane proteins in Arabidopsis:
AtAAC2 (At5g13490): A mitochondrial adenylate translocator with confirmed transport activity .
AtTic110 (At1g06950): A chloroplast inner envelope protein involved in protein import .
Unlike these proteins, At1g06470’s lack of homology to known transporters complicates functional predictions.
Systems Biology: Integrate transcriptomic and proteomic datasets to infer At1g06470’s regulatory networks.
Antibody Engineering: Develop monoclonal variants with improved specificity for high-resolution imaging.
Phenotypic Screens: Assess abiotic stress responses in At1g06470 knockdown lines.
The At1g06470 Antibody (product code CSB-PA812768XA01DOA) targets the protein encoded by the At1g06470 gene in Arabidopsis thaliana (Mouse-ear cress), corresponding to UniProt accession number Q8H184 . This antibody is specifically designed for detecting this protein in plant tissue samples and is commonly used in molecular biology research focusing on Arabidopsis as a model organism. The At1g06470 gene encodes a protein involved in plant cellular processes, and the antibody allows researchers to study its expression, localization, and function through various immunological techniques.
Epitope selection is critical for At1g06470 Antibody performance across different experimental applications. Most effective antibodies target unique, accessible epitopes that remain stable during sample processing. Different experimental conditions (native vs. denatured) affect epitope accessibility - some epitopes are only exposed after denaturation while others are conformational. When troubleshooting inconsistent results across immunoblotting, immunoprecipitation, and immunohistochemistry, researchers should consider that the epitope may be differentially accessible under various experimental conditions. This understanding follows principles similar to those used in developing other specialized antibodies, where careful epitope mapping significantly impacts antibody functionality across multiple assay formats.
Multiple complementary validation approaches should be implemented to confirm At1g06470 Antibody specificity:
Genetic knockouts/knockdowns: Compare antibody signal between wild-type plants and At1g06470 mutant lines
Recombinant protein analysis: Test against purified target protein
Western blot verification: Confirm single band of expected molecular weight
Immunoprecipitation followed by mass spectrometry: Identify all proteins captured by the antibody
Cross-reactivity testing: Evaluate against related Arabidopsis proteins
These validation methods align with best practices in antibody research that emphasize using multiple verification approaches rather than relying on a single technique, similar to methodologies described for therapeutic antibody validation programs that require comprehensive specificity testing .
Optimizing At1g06470 Antibody for successful immunoprecipitation of protein complexes requires several methodological considerations:
Buffer system optimization: Test multiple lysis buffers with varying detergent concentrations (0.1-1% NP-40, Triton X-100, or digitonin) to preserve protein-protein interactions while ensuring efficient extraction
Cross-linking protocols: Implement in vivo formaldehyde cross-linking (0.5-1%) before cell lysis to stabilize transient interactions
Antibody coupling: Covalently couple the antibody to magnetic beads using dimethyl pimelimidate (DMP) to reduce antibody contamination in the final sample
Sequential elution strategy: Develop a stepwise elution protocol using increasing stringency to distinguish between direct and indirect interactions
Control experiments: Include parallel immunoprecipitations with non-specific IgG and test in At1g06470 knockout lines
This strategy follows principles similar to those applied in therapeutic antibody development where understanding protein-protein interactions is crucial for characterizing mechanism of action .
When adapting At1g06470 Antibody for chromatin immunoprecipitation sequencing (ChIP-seq), researchers should address these critical factors:
Fixation optimization: Test formaldehyde concentrations (0.75-2%) and incubation times (5-20 minutes) to achieve optimal DNA-protein cross-linking without over-fixation
Sonication parameters: Optimize sonication conditions to achieve chromatin fragments of 200-500bp for high-resolution binding site identification
Antibody specificity validation: Perform control experiments using knockout lines and IgG controls to establish background levels
Input normalization: Collect input samples before immunoprecipitation to account for genomic biases
Technical replicates: Perform at least three biological replicates to ensure reproducibility
Sequencing depth: Aim for >10 million uniquely mapped reads for adequate coverage
This methodological approach aligns with established protocols for transcription factor ChIP-seq studies while addressing plant-specific challenges such as cell wall interference and endogenous plant phenolic compounds that can affect chromatin preparation.
Post-translational modifications (PTMs) can significantly impact At1g06470 Antibody epitope recognition through several mechanisms:
Epitope masking: Phosphorylation, glycosylation, or other PTMs may directly modify or sterically hinder the epitope
Conformational changes: PTMs can alter protein folding, affecting conformational epitope accessibility
Variable detection across tissues: The same protein may carry different PTM profiles in different cell types or under various stress conditions
To address these challenges, researchers should:
Perform phosphatase or glycosidase treatments on samples to remove specific PTMs
Use complementary antibodies recognizing different epitopes
Consider developing modification-specific antibodies if particular PTMs are research-relevant
This approach mirrors strategies used in therapeutic antibody development where understanding epitope accessibility under various conditions is crucial for predicting antibody efficacy .
When encountering weak or inconsistent signals with At1g06470 Antibody, implement this systematic troubleshooting framework:
Sample preparation optimization:
Test multiple protein extraction buffers with different detergents
Add protease inhibitor cocktails to prevent degradation
Optimize plant tissue grinding methods for complete homogenization
Antibody incubation parameters:
Test concentration ranges (1:500 to 1:5000 dilutions)
Extend primary antibody incubation time (overnight at 4°C)
Try different blocking agents (5% BSA vs. non-fat milk)
Signal enhancement approaches:
Use high-sensitivity detection systems (chemiluminescence vs. standard colorimetric)
Implement signal amplification methods
Consider antigen retrieval techniques for fixed tissues
Expression level considerations:
Target protein may be naturally low-abundance
Expression may vary with developmental stage or environmental conditions
This methodological framework addresses the most common issues that affect antibody performance in plant systems based on principles similar to those used in antibody validation studies .
To minimize non-specific background in immunohistochemistry with At1g06470 Antibody:
Sample preparation refinement:
Optimize fixation protocol (test paraformaldehyde concentrations from 2-4%)
Implement antigen retrieval methods (citrate buffer at pH 6.0)
Test different embedding mediums for better tissue preservation
Blocking optimization:
Test extended blocking times (2-4 hours)
Use species-specific serum matching secondary antibody
Add 0.1-0.3% Triton X-100 to improve penetration
Include 0.1% BSA in wash buffers to reduce non-specific binding
Antibody parameters:
Titrate primary antibody concentration
Pre-absorb antibody with plant tissue powder from related species
Reduce incubation temperature (4°C overnight instead of room temperature)
Controls implementation:
Include secondary-only controls
Use tissue from At1g06470 knockout plants as negative control
Perform peptide competition assays
This approach addresses plant-specific challenges in immunohistochemistry, including autofluorescence from cell walls and chlorophyll.
To preserve At1g06470 Antibody functionality over time:
Storage conditions:
Store antibody aliquots (10-50 μL) at -20°C for long-term storage
Avoid repeated freeze-thaw cycles (maximum 5 cycles)
For working solutions, store at 4°C with 0.02% sodium azide for up to 2 weeks
Stability enhancement:
Add stabilizing proteins (0.1-1% BSA) to diluted antibody
Consider adding glycerol (final concentration 30-50%) for freezer storage
Protect from light when fluorophore-conjugated
Quality control measures:
Document lot-to-lot variation with reference samples
Establish standard curves with positive controls
Periodically validate activity against fresh antibody
Transportation considerations:
Ship on ice or dry ice depending on duration
Monitor temperature during shipping
Allow antibody to equilibrate to room temperature before opening
These practices align with standard protocols for antibody maintenance and can significantly extend the functional lifespan of research antibodies.
For accurate quantification of protein expression using At1g06470 Antibody:
Experimental design requirements:
Include technical triplicates and biological replicates (minimum 3)
Run concentration gradients of standard samples
Use appropriate loading controls (constitutively expressed proteins)
Image acquisition parameters:
Ensure signal is within linear detection range
Maintain consistent exposure settings across all samples
Capture sufficient technical replicates
Quantification methodology:
Normalize target protein signals to loading controls
Use densitometry software with background subtraction
Apply statistical analysis appropriate for experimental design
Reporting standards:
Present raw and normalized data
Include representative images with molecular weight markers
Report antibody dilution, exposure time, and detection method
This quantification framework ensures reproducibility and statistical validity of expression analyses using immunological detection methods.
To distinguish genuine protein interactions from artifacts in co-immunoprecipitation experiments:
Control implementation:
Perform parallel IPs with non-specific IgG
Include samples from At1g06470 knockout/knockdown plants
Use reciprocal co-IP with antibodies against putative interacting partners
Stringency optimization:
Test different salt concentrations (150-500 mM NaCl) in wash buffers
Evaluate detergent stringency (0.1-1% NP-40 or Triton X-100)
Implement sequential elution with increasing stringency
Validation approaches:
Confirm interactions using orthogonal methods (e.g., proximity ligation assay)
Employ mass spectrometry to identify all co-precipitated proteins
Use recombinant protein binding assays to test direct interactions
Analysis framework:
Compare protein profiles across all control conditions
Apply statistical filters for enrichment over background
Consider known contaminants in plant IP experiments
This methodology aligns with best practices in protein interaction studies and helps minimize false positives that often confound co-immunoprecipitation experiments.
When confronted with contradictory results across different detection methods:
Epitope accessibility assessment:
Evaluate how different sample preparations affect epitope conformation
Consider that denatured vs. native conditions expose different epitopes
Test multiple antibodies targeting different regions of the same protein
Method-specific optimization:
Adjust fixation protocols for immunohistochemistry
Modify extraction buffers for Western blotting
Optimize detergent conditions for immunoprecipitation
Cross-validation framework:
Implement orthogonal detection methods (e.g., mass spectrometry)
Use genetic approaches (overexpression, knockdown) to validate antibody specificity
Consider reporter fusion proteins as complementary approach
Integration and interpretation:
Recognize that different methods reveal different aspects of protein biology
Document conditions that produce consistent results
Report discrepancies transparently in publications
This approach acknowledges that contradictory results often reflect biological reality rather than technical artifacts and provides a framework for comprehensive protein characterization.
When using At1g06470 Antibody across different plant genetic backgrounds:
Sequence conservation analysis:
Analyze epitope sequence conservation across ecotypes and species
Predict potential cross-reactivity based on homology
Consider amino acid substitutions that might affect antibody binding
Empirical cross-reactivity testing:
Validate antibody performance in major Arabidopsis ecotypes (Col-0, Ler, Ws)
Test closely related Brassicaceae species
Establish detection limits for each species
Optimization for cross-species application:
Adjust antibody concentration based on sequence divergence
Modify stringency of washing steps for non-model species
Consider developing synthetic peptide standards for calibration
Interpretation guidelines:
Document species-specific band patterns or localization differences
Account for potential paralogous proteins in comparative analyses
Report normalized values when comparing across species
This comparative approach enables broader application of At1g06470 Antibody beyond its primary target organism while maintaining scientific rigor.
Cutting-edge approaches to improve spatial resolution with At1g06470 Antibody include:
Super-resolution microscopy methods:
STORM (Stochastic Optical Reconstruction Microscopy): Achieves 20-30nm resolution
SIM (Structured Illumination Microscopy): Offers 100-120nm resolution with simpler sample preparation
Optimization of fluorophore selection for plant cell applications
Proximity labeling techniques:
APEX2 or BioID fusion proteins to identify spatial neighbors
Spatially-restricted enzymatic tagging of proteins in proximity to At1g06470
Correlation with antibody-based detection for validation
Correlative light and electron microscopy:
Immunogold labeling for TEM visualization
CLEM approaches to bridge scales from tissue to ultrastructural levels
Software tools for multi-scale image registration
Tissue-specific analysis approaches:
Laser capture microdissection combined with immunoblotting
Tissue clearing methods compatible with immunolabeling
Whole-mount immunostaining protocols for intact organs
These advanced techniques parallel methodologies used in therapeutic antibody development where precise localization can inform mechanism of action studies .
Emerging computational approaches offer significant potential for developing enhanced At1g06470 Antibodies:
AI-driven epitope prediction:
Rational antibody engineering:
In silico cross-reactivity assessment:
Proteome-wide screening for potential off-targets
Prediction of binding to protein isoforms or closely related family members
Computational assessment of epitope conservation across species
Performance prediction:
Modeling antibody behavior under different experimental conditions
Predicting stability and shelf-life characteristics
Correlation between sequence properties and functionality in different assays
These computational approaches represent the frontier of antibody development and may address many current limitations of plant research antibodies.
Beyond conventional applications, At1g06470 Antibody could be leveraged for:
Single-cell proteomics:
Antibody-based microfluidic sorting of specific cell populations
Single-cell Western blotting for heterogeneity analysis
Mass cytometry (CyTOF) for multi-parameter cellular analysis
Biosensor development:
FRET-based sensors utilizing antibody fragments
Surface plasmon resonance platforms for continuous monitoring
Antibody-functionalized nanomaterials for in vivo imaging
Synthetic biology applications:
Antibody-based modulation of protein function
Construction of artificial protein networks using antibody-based scaffolds
Targeted protein degradation systems using antibody-degrader conjugates
Environmental monitoring:
Field-deployable immunochromatographic assays
Antibody-functionalized electrochemical sensors
Remote detection systems for agricultural applications